6 research outputs found
The Suppression of Adjuvant-induced Inflammation and the Inhibition of the Serum and Tissue IL-17, TNF-α and IL-1β levels by Thymol and Carvacrol
Background and Aim: Thymol and carvacrol are two important components of thyme that have multiple medicinal uses. This study investigates the in vivo effects of these natural products on adjuvant-induced inflammation and secretion of interleukin (IL)-17 and key inflammatory cytokines in rats.
Materials and Methods: We injected complete Freund’s adjuvant (CFA) into the hind paws of rats in order to induce inflammation. Each of the CFA-treated rat groups received gavages of thymol, carvacrol, or vehicle (CFA-only group). Rats’ paws and ankle edema were measured and then we were able to determine an inflammatory score based on the results. After 72 h of inflammation induction, sera were collected and subsequently inflamed tissue extracts were prepared for cytokine assay by ELISA.
Results: Both components significantly decreased paw edema in rats (p<0.01). Thymol decreased ankle edema to 61.6% of edema in CFA-only rats (p<0.001). We observed a decreased inflammatory score in the thymol and carvacrol-treated rats. The evaluation of the tissue and serum inflammatory cytokine levels showed that both components decreased tumor necrosis factor (TNF)-α levels (p<0.05). Thymol and carvacrol reduced interleukin (IL)-1β serum and tissue levels, respectively. These components reduced tissue levels of IL-17 from 148.4±13.4pg/ml in CFA-only rats to 90.1±18.9pg/ml (thymol) and 82.3±9.2pg/ml (carvacrol). Both components decreased serum IL-17 levels in rats (p<0.05). In comparison, the anti-inflammatory drug, indomethacin, reduced the inflammatory score and decreased tissue TNF-α and IL-1β levels but did not affect IL-17 production.
Conclusion: Carvacrol and thymol could relieve inflammation symptoms possibly by downregulating serum and tissue IL-17 expression in addition to key pro-inflammatory cytokines, TNFα and IL-1β
A review of the critical role of vitamin D axis on the immune system
In recent years, the physiological and molecular functions of vitamin D (Vit-D) have been deeply investigated. At first, Vit-D was considered a regulator of mineral and skeletal homeostasis. However, due to the extensive-expression pattern of Vit-D receptor (VDR) in almost every non-skeletal cell, Vit-D is considered mainly a multifunctional agent with broad effects on various tissues, notably the immune system. The expression of VDR in immune cells such as dendritic cells, monocyte/macrophage, neutrophils, B cells and T cells has been well demonstrated. Besides, such immune cells are capable of metabolizing the active form of Vit-D which means that it can module the immune system in both paracrine and autocrine manners. Vit-D binding protein (DBP), that regulates the levels and homeostasis of Vit-D, is another key molecule capable of modulating the immune system. Recent studies indicate that dysregulation of Vit-D axis, variations in the DBP and VDR genes, and Vit-D levels might be risk factors for the development of autoimmune disease. Here, the current evidence regarding the role of Vit-D axis on the immune system, as well as its role in the development of autoimmune disease will be clarified. Further insight will be given to those studies that investigated the association between single nucleotide polymorphisms of DBP and VDR genes with autoimmune disease susceptibility
Modulation of Cytokine Production and Transcription Factors Activities in Human Jurkat T Cells by Thymol and Carvacrol
Purpose: Thymol and carvacrol, two main
components of thyme, have
shown anti-inflammatory effects. The aim of this study was to assess the effects of these
components on Jurkat leukemia cells as an in vitro T cell model and their
molecular mechanisms of activity.
Methods: Cells were cultured in the
presence of components and subsequently stimulated with
phorbol-12-myristate-13-acetate (PMA)/calcium ionophore for evaluating
interleukin (IL)-2 and interferon (IFN)-γ production. The activation of T cell
transcription factors that included nuclear factors of activated T cells
(NFATs), activator protein-1 (AP-1; c-Jun/c-Fos), and nuclear factor (NF)-KB
were examined by Western blot analysis.
Results: Thymol and carvacrol at 25 µg/ml
significantly reduced IL-2 levels from 119.4 ± 8pg/ml in control cells treated only with
PMA/Calcium ionophore
and the solvent to
66.9 ± 6.4pg/ml (thymol) and 32.3 ± 3.6pg/ml (carvacrol) and IFN-γ from 423.7 ±
19.7pg/ml in control cells to 311.9 ± 11.6pg/ml
(thymol) and 293.5 ± 16.7pg/ml (carvacrol). Western blot analyses of nuclear extracts showed that
the same concentrations of components significantly reduced NFAT-2 to 44.2 ± 2.7% (thymol) and 91.4
± 2.3% (carvacrol) of the control (p<0.05), and c-Fos to 31.2 ± 6.2% (thymol) and 27.6 ± 3.1% (carvacrol) of
the control (p<0.01). No effects on NFAT-1, c-Jun and
phospho-NF-KBp65 levels were
observed.
Conclusion: Thymol
and carvacrol could contribute to modulation of T cell activity by reducing
IL-2 and IFN-γ production possibly through down regulation of AP-1 and NFAT-2 transcription factors suggesting their potential
usefulness for reduction of T cell overactivity in immune-mediated diseases